Effective Clinical Supply Strategy for Rare Disease

Rawle Dundas, Associate Director, Global Clinical Supply, Alexion gave this presentation at the 2019 Clinical Trial Supply forum, covering:

  • Discuss the ways that Alexion are approaching the challenge of supplying CTS for rare disease clinical programs
  • Analyses how to manage risk of IP stock out with limited drug expiry
  • Examine how to create a lean and efficient product supply strategy for multi country trials with a very small patient enrollment

View the presentation by submitting your email below:



Please note: That all fields marked with an asterisk (*) are required.